Dream Pharma to introduce new asthma inhaler

Published: 2008-08-20 06:55:00
Updated: 2008-08-20 06:55:00
Dream Pharma Corp. says it has signed an exclusive agreement with Belgium based Laboratoires SMB to locally distribute 'Flutaxa', a dry inhaler for treatment of asthma in 2010.

Flutaxa inhaler, containing fluticasone propionate and supra, delivers the ingredients directly into the lungs where ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.